Back to search

Article

Antiviral Potential of Lauric Acid against Dengue Virus 2: Evidence from a Luciferase-Based Replicon Assay

2026-04-23

Abstract excerpt

<h4>ABSTRACT</h4> Dengue virus (DENV) infection generates a significant health burden throughout the world, and there are no clinically approved antiviral drugs, as of now. The virus also depends on lipid metabolism in the host to conduct effective replication and this makes lipid-directed compounds promising as therapeutic options. We assessed the antiviral effect of lauric acid, a 12-carbon medium-chain fatty a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e265b85e-12da-5ea1-97ce-00c27f29ad41
DOI
10.64898/2026.04.23.720334
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Antiviral Potential of Lauric Acid against Dengue Virus 2: Evidence from a Luciferase-Based Replicon AssayDOI 10.64898/2026.04.23.720334
Select a neighboring publication to make it the new centre.